Post-translational Modifications of IκBα: The State of the Art-Reference-Cited by-同舟云学术

Post-translational Modifications of IκBα: The State of the Art

Published:2020-11-05 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Wang Xiuli,Peng Hanlin,Huang Yaqian,Kong Wei,Cui Qinghua,Du Junbao,Jin Hongfang

Funder

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference141 articles.

1. Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha.;Abu-Amer;J. Biol. Chem.,1998

2. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.;Aguilera;Proc. Natl. Acad. Sci. U.S.A.,2004

3. Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity.;Aillet;PLoS One,2012

4. Atypical IκB proteins in immune cell differentiation and function.;Annemann;Immunol. Lett.,2016

5. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm.;Arenzana-Seisdedos;J. Cell Sci.,1997

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between SUMOylation and other post-translational modifications in breast cancer;Cellular & Molecular Biology Letters;2024-08-10

2. Netrin‑4 promotes VE‑cadherin expression in endothelial cells through the NF‑κB signaling pathway;Experimental and Therapeutic Medicine;2024-07-04

3. NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids;Scientific Reports;2024-07-04

4. A Pair of Epimers of Lignan Alleviate Neuroinflammatory Effects by Modulating iNOS/COX-2 and MAPK/NF-κB Signaling Pathways;Inflammation;2024-06-15

5. Impact of NF-κB Signaling and Sirtuin-1 Protein for Targeted Inflammatory Intervention;Current Pharmaceutical Biotechnology;2024-04-17